Non-mucin extracellular proteins and glycoproteins

Non-mucin extracellular proteins and glycoproteins constitute a vast and heterogeneous group of molecules that are secreted into the extracellular environment and lack the dense O-glycan clusters characteristic of mucins (Hynes & Naba, 2012, Cold Spring Harb Perspect Biol). This category includes the core components of the extracellular matrix (ECM), such as collagens, elastins, and fibronectins, which provide the essential physical scaffolding for tissues (Naba et al., 2012, Mol Cell Proteomics). Beyond structural support, these proteins function as critical regulators of cell signaling by sequestering growth factors and interacting with cell-surface receptors like integrins to influence cell survival and migration (Moremen & Haltiwanger, 2019, Nat Chem Biol). In clinical contexts, the dysregulation of these proteins is a primary driver of pathological processes including organ fibrosis, cardiovascular disease, and the formation of the tumor microenvironment (UniProt, 2024). While the category itself is too broad to be a single drug target, many individual members are targeted by therapeutics, such as bevacizumab for VEGF or collagenase for structural degradation (PubMed, 2023). Consequently, this group is of high interest for biomarker development and targeted therapy, though systemic targeting of such ubiquitous proteins poses significant safety challenges regarding tissue integrity and wound healing (StatPearls, 2023).

Other names

Extracellular matrix proteinsSecreted glycoproteinsMatrisome proteinsNon-mucin glycoproteinsECM proteins

Drugs targeting members of this class typically function by neutralizing secreted signaling molecules, enzymatically degrading structural matrix components to relieve physical contractures, or blocking the interaction between extracellular ligands and their cognate cell-surface receptors (PubMed, 2023).